Rather than attempting to suppress cravingswhich can sometimes intensify themACT encourages acknowledging thoughts whilst choosing actions aligned with personal values
The question in failure-to-warn cases becomes: when did Novo Nordisk know or should have known about gastroparesis and NAION risks, and when should the company have updated warnings
Balodis IM, Kober H, Worhunsky PD, White MA, Stevens MC, Pearlson GD, et al
Empagliflozin does not inhibit any of these human uptake transporters at clinically relevant plasma concentrations and, therefore, no effect of empagliflozin is anticipated on concomitantly administered drugs that are substrates of these uptake transporters
Novo Nordisk and Eli Lilly Pricing Agreements The $50/month copay is possible because of pricing agreements between CMS and the two major GLP-1 manufacturers